| Anti-LGI1 encephalitis: clinical syndrome and long-term follow-up A van Sonderen, RD Thijs, EC Coenders, LC Jiskoot, E Sanchez, ... Neurology 87 (14), 1449-1456, 2016 | 556 | 2016 |
| Evaluation of seizure treatment in anti-LGI1, anti-NMDAR, and anti-GABABR encephalitis MAAM de Bruijn, A van Sonderen, MH van Coevorden-Hameete, ... Neurology 92 (19), e2185-e2196, 2019 | 234 | 2019 |
| The relevance of VGKC positivity in the absence of LGI1 and Caspr2 antibodies A van Sonderen, MWJ Schreurs, MAAM De Bruijn, S Boukhrissi, ... Neurology 86 (18), 1692-1699, 2016 | 164 | 2016 |
| Neurologic syndromes related to anti-GAD65: clinical and serologic response to treatment A Muñoz-Lopetegi, MAAM de Bruijn, S Boukhrissi, AEM Bastiaansen, ... Neurology: Neuroimmunology & Neuroinflammation 7 (3), e696, 2020 | 127 | 2020 |
| Long-term neuropsychological outcome following pediatric anti-NMDAR encephalitis MAAM De Bruijn, FK Aarsen, MP Van Oosterhout, MM Van Der Knoop, ... Neurology 90 (22), e1997-e2005, 2018 | 119 | 2018 |
| The expanded clinical spectrum of anti-GABABR encephalitis and added value of KCTD16 autoantibodies MH van Coevorden-Hameete, MAAM de Bruijn, E de Graaff, ... Brain 142 (6), 1631-1643, 2019 | 79 | 2019 |
| Pediatric autoimmune encephalitis: recognition and diagnosis MAAM de Bruijn, AL Bruijstens, AEM Bastiaansen, A van Sonderen, ... Neurology: Neuroimmunology & Neuroinflammation 7 (3), e682, 2020 | 66 | 2020 |
| Predictive value of electroencephalography in anti-NMDA receptor encephalitis A van Sonderen, S Arends, DLJ Tavy, AEM Bastiaansen, MAAM De Bruijn, ... Journal of Neurology, Neurosurgery & Psychiatry 89 (10), 1101-1106, 2018 | 64 | 2018 |
| Antibodies contributing to focal epilepsy signs and symptoms score MAAM de Bruijn, AEM Bastiaansen, H Mojzisova, A van Sonderen, ... Annals of Neurology 89 (4), 698-710, 2021 | 48 | 2021 |
| Autoimmune encephalitis resembling dementia syndromes AEM Bastiaansen, RW van Steenhoven, MAAM de Bruijn, YS Crijnen, ... Neurology: Neuroimmunology & Neuroinflammation 8 (5), e1039, 2021 | 34 | 2021 |
| Anti-NMDAR encephalitis in the Netherlands, focusing on late-onset patients and antibody test accuracy AEM Bastiaansen, MAAM de Bruijn, SL Schuller, E Martinez-Hernandez, ... Neurology: Neuroimmunology & Neuroinflammation 9 (2), e1127, 2021 | 22 | 2021 |
| Anti-NMDAR encephalitis and other glutamate and GABA receptor antibody encephalopathies MAAM De Bruijn, MJ Titulaer Handbook of clinical neurology 133, 199-217, 2016 | 14 | 2016 |
| Phase II trial of natalizumab for the treatment of anti-Hu associated paraneoplastic neurological syndromes AEM Bastiaansen, AHC de Jongste, MAAM de Bruijn, YS Crijnen, ... Neuro-Oncology Advances 3 (1), vdab145, 2021 | 9 | 2021 |
| Antistofgeassocieerde Encephalitis: Handvatten Voor Diagnostiek En Behandeling A Sonderen, M Schreurs, M de Bruijn, P Sillevis Smitt, M Titulaer Tijdschrift voor Neurologie en Neurochirurgie 117 (2), 78-88, 2016 | | 2016 |
